201 related articles for article (PubMed ID: 36890519)
1. Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms.
Giordani B; Naldi M; Croatti V; Parolin C; Erdoğan Ü; Bartolini M; Vitali B
Microb Cell Fact; 2023 Mar; 22(1):45. PubMed ID: 36890519
[TBL] [Abstract][Full Text] [Related]
2. Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis.
Croatti V; Parolin C; Giordani B; Foschi C; Fedi S; Vitali B
Microb Cell Fact; 2022 Nov; 21(1):237. PubMed ID: 36376912
[TBL] [Abstract][Full Text] [Related]
3. Insight into phenotypic and genotypic differences between vaginal
Costantini PE; Firrincieli A; Fedi S; Parolin C; Viti C; Cappelletti M; Vitali B
Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34096840
[TBL] [Abstract][Full Text] [Related]
4. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
[TBL] [Abstract][Full Text] [Related]
5. Impact of Exopolysaccharides (EPSs) of Lactobacillus gasseri strains isolated from human vagina on cervical tumor cells (HeLa).
Sungur T; Aslim B; Karaaslan C; Aktas B
Anaerobe; 2017 Oct; 47():137-144. PubMed ID: 28554813
[TBL] [Abstract][Full Text] [Related]
6. Vaginal
Parolin C; Croatti V; Giordani B; Vitali B
Microorganisms; 2022 Oct; 10(10):. PubMed ID: 36296367
[No Abstract] [Full Text] [Related]
7. Probiotic and Metabolic Characterization of Vaginal Lactobacilli for a Potential Use in Functional Foods.
D'Alessandro M; Parolin C; Bukvicki D; Siroli L; Vitali B; De Angelis M; Lanciotti R; Patrignani F
Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33919838
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of probiotic properties in human vaginal lactobacilli strains.
Hütt P; Lapp E; Štšepetova J; Smidt I; Taelma H; Borovkova N; Oopkaup H; Ahelik A; Rööp T; Hoidmets D; Samuel K; Salumets A; Mändar R
Microb Ecol Health Dis; 2016; 27():30484. PubMed ID: 27527701
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Assessment of Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 as a Potential Vaginal Probiotic Candidate.
Ahire JJ; Sahoo S; Kashikar MS; Heerekar A; Lakshmi SG; Madempudi RS
Probiotics Antimicrob Proteins; 2023 Apr; 15(2):275-286. PubMed ID: 34417721
[TBL] [Abstract][Full Text] [Related]
10. Culture Supernatants of Lactobacillus gasseri and L. crispatus Inhibit Candida albicans Biofilm Formation and Adhesion to HeLa Cells.
Matsuda Y; Cho O; Sugita T; Ogishima D; Takeda S
Mycopathologia; 2018 Aug; 183(4):691-700. PubMed ID: 29603066
[TBL] [Abstract][Full Text] [Related]
11.
Parolin C; Croatti V; Laghi L; Giordani B; Tondi MR; De Gregorio PR; Foschi C; Vitali B
Front Microbiol; 2021; 12():750368. PubMed ID: 34777300
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of probiotic lactobacilli supernatants on single and mixed non-albicans Candida species biofilm.
Tan Y; Leonhard M; Moser D; Ma S; Schneider-Stickler B
Arch Oral Biol; 2018 Jan; 85():40-45. PubMed ID: 29031236
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of vaginal
Takano T; Kudo H; Eguchi S; Matsumoto A; Oka K; Yamasaki Y; Takahashi M; Koshikawa T; Takemura H; Yamagishi Y; Mikamo H; Kunishima H
Front Cell Infect Microbiol; 2023; 13():1113401. PubMed ID: 37201113
[TBL] [Abstract][Full Text] [Related]
14. Vaginal Lactobacilli Reduce
Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A
Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390
[TBL] [Abstract][Full Text] [Related]
15. In-vitro effect of vaginal lactobacilli against group B Streptococcus.
Marziali G; Foschi C; Parolin C; Vitali B; Marangoni A
Microb Pathog; 2019 Nov; 136():103692. PubMed ID: 31445119
[TBL] [Abstract][Full Text] [Related]
16. Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.
Siroli L; Patrignani F; Serrazanetti DI; Parolin C; Ñahui Palomino RA; Vitali B; Lanciotti R
Front Microbiol; 2017; 8():166. PubMed ID: 28223974
[TBL] [Abstract][Full Text] [Related]
17. Prebiotic Activity of Vaginal Lactobacilli on Bifidobacteria: from Concept to Formulation.
Giordani B; Abruzzo A; Parolin C; Foschi C; Laghi L; Marangoni A; Luppi B; Vitali B
Microbiol Spectr; 2023 Feb; 11(1):e0200922. PubMed ID: 36602371
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.
Scillato M; Spitale A; Mongelli G; Privitera GF; Mangano K; Cianci A; Stefani S; Santagati M
Microbiologyopen; 2021 Feb; 10(2):e1173. PubMed ID: 33970542
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Inhibitory Effects of
He Y; Niu X; Wang B; Na R; Xiao B; Yang H
Front Med (Lausanne); 2020; 7():284. PubMed ID: 32637420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
